Abstract
Background
To avoid the loss of fertility, chemotherapy should be chosen as an adjuvant treatment after trachelectomy. Our study evaluated the effectiveness and safety of adjuvant chemotherapy after abdominal trachelectomy for cervical cancer.
Methods
Our institutional review board approved this clinical study, and informed consent was obtained from each patient. We began performing abdominal trachelectomy at our institution in 2005. Deep stromal invasion (more than two-thirds) with lymphovascular space invasion, diffuse cervical invasion, skip lesions in the vagina, and lymphovascular space invasion in the cardinal ligament and vagina were defined as intermediate-risk factors, and parametrial invasion and pelvic lymph node metastasis were defined as high-risk factors. Patients who had intermediate- or high-risk factors received post-trachelectomy adjuvant treatment. The medical records and information of the patients were reviewed retrospectively.
Results
Through January 2020, we performed 212 trachelectomies. Among the included patients, 16 and 7 patients with intermediate- and high-risk cancer, respectively, received adjuvant chemotherapy after trachelectomy (2 and 21 patients underwent abdominal modified radical trachelectomy and radical trachelectomy, respectively). Among these patients, only one (4.3%) experienced relapse and subsequent death of the disease after a median postoperative follow-up of 80 months (range 12–146 months). The 5-year survival rate was 95.5%. Chemotherapy-related life-threatening acute adverse events were not observed. Persistent ovarian dysfunction and late adverse events did not occur. One woman achieved three pregnancies, and two infants were delivered.
Conclusion
Adjuvant chemotherapy after abdominal trachelectomy could be an alternative treatment option from the aspects of effectiveness, safety, and fertility preservation.
Similar content being viewed by others
References
World Health Organization (2020) Cervical cancer. https://www.who.int/health-topics/cervical-cancer. Accessed Apr 2020
NCCN Clinical Practice Guidelines in Oncology (2020) Cervical Cancer Version 1.2020. https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf. Accessed Apr 2020
Ebina Y, Mikami M, Nagase S et al (2019) Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer. Int J Clin Oncol 24:1–19
Matsuo K, Shimada M, Yokota H et al (2017) Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer. Oncotarget 8:106866–106875
Matsuo K, Shimada M, Aoki Y et al (2017) Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation. Int J Cancer 141:1042–1051
Lee KB, Shim SH, Lee JM (2018) Comparison between adjuvant chemotherapy and adjuvant radiotherapy/chemoradiotherapy after radical surgery in patients with cervical cancer: a meta-analysis. J Gynecol Oncol 29(4):e62
Dargent D, Martin X, Sacchetoni A et al (2000) Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients. Cancer 88:1877–1882
Marchiole P, Benchaib M, Buenerd A et al (2007) Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent’s operation): a comparative study with laparoscopic-assisted vaginal radical hysterectomy (LARVH). Gynecol Oncol 106:132–141
Okugawa K, Kobayashi H, Sonoda K et al (2017) Oncologic and obstetric outcomes and complications during pregnancy after fertility-sparing abdominal trachelectomy for cervical cancer: a retrospective review. Int J Clin Oncol 22:340–346
Ogawa S, Kobayashi H, Amada S et al (2010) Sentinel node detection with (99m) Tc phytate alone is satisfactory for cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy. Int J Clin Oncol 15:52–58
Yahata H, Kobayashi H, Sonoda K et al (2018) Prognostic outcome and complications of sentinel lymph node navigation surgery for early-stage cervical cancer. Int J Clin Oncol 23:1167–1172
Sonoda K, Yahata H, Okugawa K et al (2018) Value of intraoperative cytological and pathological sentinel lymph node diagnosis in fertility-sparing trachelectomy for early-stage cervical cancer. Oncology 94:92–98
Peters WA 3rd, Liu PY, Barrett RJ 2nd et al (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18:1606–1613
Sedlis A, Bundy BN, Rotman MZ et al (1999) A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 73:177–183
Kamura T, Tsukamoto N, Tsuruchi N et al (1992) Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer 69:181–186
Cibula D, Abu-Rustum NR, Dusek L et al (2012) Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol Oncol 124:496–501
Colturato LF, Signorini Filho RC, Fernandes RC et al (2016) Lymph node micrometastases in initial stage cervical cancer and tumoral recurrence. Int J Gynecol Obstet 133:69–75
Okugawa K, Yahata H, Sonoda K et al (2020) Safety evaluation of abdominal trachelectomy in patients with cervical tumors ≥ 2 cm: a single-institution, retrospective analysis. J Gynecol Oncol 31(4):e41
Machida H, Iwata T, Okugawa K et al (2020) Fertility-sparing trachelectomy for early-stage cervical cancer: a proposal of an ideal candidate. Gynecol Oncol 156:341–348
Hosaka M, Watari H, Kato T et al (2012) Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy. J Surg Oncol 105(6):612–616
Monk BJ, Sill MW, McMeekin DS et al (2009) Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 27:4649–4655
Sehouli J, Runnebaum IB, Fotopoulou C et al (2012) A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study. Ann Oncol 23:2259–2264
Pareja R, Rendón GJ, Sanz-Lomana CM et al (2013) Surgical, oncological, and obstetrical outcomes after abdominal radical trachelectomy - a systematic literature review. Gynecol Oncol 131:77–82
Sandadi S, Tanner EJ, Khoury-Collado F et al (2013) Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications. Int J Gynecol Cancer 23:553–558
Barter JF, Soong SJ, Shingleton HM et al (1989) Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol 32:292–296
Nakamura K, Kitahara Y, Satoh T et al (2016) Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study). World J Surg Oncol 14:173. https://doi.org/10.1186/s12957-016-0931-4
Chen MF, Tseng CJ, Tseng CC et al (2007) Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 67:1438–1444
Loren AW, Mangu PB, Beck LN et al (2013) Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2500–2510
Acknowledgements
The authors thank Masako Kijima, Nobuko Yasutake, Hironori Kenjo, and Emiko Hori for their technical assistance. We also thank Joe Barber Jr., Ph.D., and H. Nikki March, Ph.D., from Edanz Group (https://en-author-services.edanzgroup.com/ac), for editing a draft of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Okugawa, K., Yahata, H., Sonoda, K. et al. Evaluation of adjuvant chemotherapy after abdominal trachelectomy for cervical cancer: a single-institution experience. Int J Clin Oncol 26, 216–224 (2021). https://doi.org/10.1007/s10147-020-01778-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-020-01778-8